Back to results
US 2026/0200855 A1Published application
Vanillin pyridine carboxylates
AssigneeRenovel Innovations, Inc.
InventorsBishwajit NAG, Ananda Sen, Nitish Nag, Srinivasan Narasimahan
Life of this patent
Estimating the term…
Abstract
Novel Vanillin Pyridine Carboxylates are provided which exhibit activity for the treatment of immunological diseases, inflammation, obesity, hyperlipidemia, hypertension, neurological diseases and diabetes, and for reducing plasma glucose, free fatty acids, cholesterol, and triglyceride levels, and for treating obesity, autoimmune diseases, inflammation, immunological disease, and disorders associated with insulin resistance.
Claims14
A compound formula I
- wherein, B, C, E are selected from Hydrogen, Hydroxyl, Alkoxy, alkyl groups with straight chain or branched and halogens like Chlorine, Fluorine, Bromine and Iodine;
- R1 can be selected from groups like Hydrogen, Hydroxyl, Alkoxy, alkyl groups with straight chain or branched and halogens like Chlorine, Fluorine, Bromine and Iodine;
- and R3 is a methyl group;
- and R2 can be selected from amino acids (naturally occurring and synthetic), their corresponding amino acid alcohols and amino acid esters, hydroxylamines and 2,4 or 3,5 disubstituted phenyl hydrazines where the substituents can be H, Halogens or Nitro group;
- and salts or derivatives thereof.
2 more elements
Dependencies are inferred from the claim text.